Novozymes A/S (OTCMKTS:NVZMY) Sees Unusually-High Trading Volume – Time to Buy?

Novozymes A/S (OTCMKTS:NVZMYGet Free Report) saw strong trading volume on Tuesday . 143,190 shares changed hands during mid-day trading, an increase of 263% from the previous session’s volume of 39,453 shares.The stock last traded at $62.73 and had previously closed at $64.20.

Wall Street Analyst Weigh In

Separately, Zacks Research cut shares of Novozymes A/S from a “strong-buy” rating to a “hold” rating in a report on Monday, August 25th. Two equities research analysts have rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy”.

Read Our Latest Stock Report on NVZMY

Novozymes A/S Trading Down 2.2%

The company’s 50-day moving average price is $67.90 and its 200-day moving average price is $65.32. The firm has a market cap of $29.39 billion, a price-to-earnings ratio of 39.72, a price-to-earnings-growth ratio of 1.26 and a beta of 0.93. The company has a quick ratio of 1.04, a current ratio of 1.66 and a debt-to-equity ratio of 0.11.

Novozymes A/S Cuts Dividend

The firm also recently declared a dividend, which will be paid on Thursday, September 11th. Investors of record on Wednesday, September 3rd will be given a dividend of $0.1856 per share. The ex-dividend date is Tuesday, September 2nd. This represents a yield of 88.0%. Novozymes A/S’s payout ratio is presently 48.10%.

About Novozymes A/S

(Get Free Report)

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

Featured Articles

Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.